Insider · CIK 0001738081
Adam S. Mostafa
Files at XFOR (X4 Pharmaceuticals, Inc). First filing Nov 3, 2023, latest Nov 3, 2023.
In brief
Adam S. Mostafa files SEC Form 4 as CFO at XFOR (X4 Pharmaceuticals, Inc). Since Nov 3, 2023, Adam S. Mostafa has reported 0 open-market buys worth $0 and 1 open-market sell worth $168k, the latest filed on Nov 3, 2023.
A track record needs three past buys with six months of prices behind them; Adam S. Mostafa has 0, so none is measured yet.
The newest scored trade: sold $168k of XFOR on Nov 1, 2023, filed Nov 3, 2023, scored 48 (moderate), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XFOR: X4 Pharmaceuticals, Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | X4 Pharmaceuticals, Inc | $168k 230,645 shares | -74% | +9% from low-70% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 24, 2025 | XFOR X4 Pharmaceuticals, Inc | 74,773 0.04% of outstanding | $39k | Oct 7, 2024 | none |
| Mar 11, 2024 | XFOR X4 Pharmaceuticals, Inc | 52,500 0.03% of outstanding | $47k | Mar 11, 2024 | $28k |
| Feb 12, 2024 | XFOR X4 Pharmaceuticals, Inc | 27,721 0.02% of outstanding | $27k | Feb 12, 2024 | none |
| Nov 1, 2023 | XFOR X4 Pharmaceuticals, Inc | 230,645 0.14% of outstanding | $182k | Nov 1, 2023 | none |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 1, 2023 | XFOR X4 Pharmaceuticals, Inc | SOpen-market sale Common Stock10b5-1 | -230,645 | $0.73 | $168k | 80,221 | Nov 3, 2023 |
| Oct 31, 2023 | XFOR X4 Pharmaceuticals, Inc | AGrant or award Common Stock | +230,645 | $0.00 | $0 | 310,866 | Nov 2, 2023 |
Questions about Adam S. Mostafa
Answered from the filings on this page, as of the latest one.
Is Adam S. Mostafa buying or selling?
Not in the last 12 months. Adam S. Mostafa's latest open-market trade on SEC Form 4 was sold $168k of XFOR on Nov 1, 2023.
How did Adam S. Mostafa's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adam S. Mostafa has 0.
Where does Adam S. Mostafa file Form 4?
Adam S. Mostafa has filed Form 4 at XFOR (X4 Pharmaceuticals, Inc) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.